000			01435 a2200409 4500
005			20250515045210.0
264		0	_c20070201
008			200702s 0 0 eng d
022			_a1523-3774
024	7		_a10.1007/s11926-006-0041-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aHashkes, Philip J
245	0	0	_aUpdate on the medical treatment of juvenile idiopathic arthritis. _h[electronic resource]
260			_bCurrent rheumatology reports _cDec 2006
300			_a450-8 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAntibodies, Blocking _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntirheumatic Agents _xtherapeutic use
650	0	4	_aArthritis, Juvenile _xdrug therapy
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xtherapeutic use
650	0	4	_aInfliximab
650	0	4	_aIsoxazoles _xtherapeutic use
650	0	4	_aLeflunomide
650	0	4	_aMeloxicam
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aNaproxen _xtherapeutic use
650	0	4	_aRheumatology _xmethods
650	0	4	_aThiazines _xtherapeutic use
650	0	4	_aThiazoles _xtherapeutic use
700	1		_aLaxer, Ronald M
773	0		_tCurrent rheumatology reports _gvol. 8 _gno. 6 _gp. 450-8
856	4	0	_uhttps://doi.org/10.1007/s11926-006-0041-3 _zAvailable from publisher's website
999			_c16665425 _d16665425